Gary W. Herschman, Health Care Mergers and Acquisitions attorney, in the firm’s Newark office, was quoted in Becker’s ASC Review, in “Private Equity's New Target Could Be Good News for ASCs,” by Patsy Newitt.
Following is an excerpt:
After years of courting ASCs, gastroenterology groups and ophthalmology groups, private equity has set its sights on cardiology, a high-acuity growth opportunity for ASCs. …
Cardiology groups are the latest focus of healthcare investors, Gary Herschman, of the law firm Epstein Beckers Green, [discussed] in a Nov. 9 [webinar]. Currently, there are six active private equity cardiology platforms, according to Mr. Herschman, adding that the number is expected to double in the next 12 to 18 months. …
This could be good news for ASCs, who have been eyeing cardiology as more procedures move to the outpatient setting.
Cardiology procedures received the highest estimated Medicare payment increases in 2021, making it the fastest growing ASC specialty, according to Avanza's "2022 Key ASC Benchmarks and Industry Figures" report. A 2020 Bain & Co. report projected that by the mid-2020s, 33 percent of cardiology procedures will be performed in ASCs, a 23 percent increase from 2018.
People
Board of Directors / Member of the Firm
